Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Interview
  • Published:

Future investments

The European Commission has identified photonics as a key technology for the future health of European industry. Nature Photonics spoke to Gustav Kalbe, Head of Sector at the Photonics Unit, about how he and his colleagues are influencing photonics research.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gevaux, D. Future investments. Nature Photon 3, 2–3 (2009). https://doi.org/10.1038/nphoton.2008.255

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nphoton.2008.255

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing